Cat. No JK276530_100_MG
J&K Chemical

Product Information

Product Name
Tadalafil, 98%, reference material
Brand Name
J&K
Product Number
276530
CAS
171596-29-5
Molecular Formula
C22H19N3O4
Molecular Weight
389.41
Certificate of Analysis (COA)​
COA not found

General Information

PubChem CID
110635
IUPAC Name
(2R,8R)-2-(1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo8.7.0.03,8.011,16heptadeca-1(10),11,13,15-tetraene-4,7-dione
InChI Key
WOXKDUGGOYFFRN-IIBYNOLFSA-N
SMILES
CN1CC(=O)N2C@@H(C1=O)CC3=C(C@H2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36

Properties

Melting Point
193

Safety Information

GHS Symbols
Hazard Symbol
Signal Word
Warning
Hazard Statement
H315
H319
H335
Precautionary Statement
P280
P321
P261
P271
P319
P405
P501
P302+P352
P332+P317
P362+P364
P264+P265
P305+P351+P338
P337+P317
P304+P340
P403+P233
Storage Condition
Freezer -20℃

References Data Source From Pubchem

Correction: Endovascular therapy for erectile dysfunction: insights from more than 1000 treatments

Publication Name: CVIR Endovascular
Publication Date: 2026-07-03
DOI: 10.1186/s42155-026-00666-y|10.1186/s42155-026-00723-6

Correction: Hyperbaric oxygen therapy attenuates urethral stricture formation after urethral injury: an experimental rabbit study

Publication Name: World Journal of Urology
Publication Date: 2026-05-11
DOI: 10.1007/s00345-026-06323-2|10.1007/s00345-026-06382-5

Status of Clinical Care of Duchenne Muscular Dystrophy: Global Perspective and Situation in India

Publication Name: Indian Journal of Pediatrics
Publication Date: 2026-03-04
DOI: 10.1007/s12098-025-05975-z

The impact of minimally invasive surgical therapy for Benign prostatic hyperplasia on sexual function: a systematic review and meta-analysis

Publication Name: Prostate Cancer and Prostatic Diseases
Publication Date: 2026-03-03
DOI: 10.1038/s41391-026-01091-x

Tadalafil, 98%, reference material

Just added to your wishlist:
My Wishlist
You've just added this product to the cart:
Go to cart page